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Atrial natriuretic factor receptor guanylate cyclase (ANF-RGC), was the ﬁrst discovered
member of the mammalian membrane guanylate cyclase family.The hallmark feature of the
family is that a single protein contains both the site for recognition of the regulatory signal
and the ability to transduce it into the production of the second messenger, cyclic GMP.
For over two decades, the family has been classiﬁed into two subfamilies, the hormone
receptor subfamily with ANF-RGC being its paramount member, and the Ca2+ modulated
subfamily, which includes the rod outer segment guanylate cyclases, ROS-GC1 and 2, and
the olfactory neuroepithelial guanylate cyclase. ANF-RGC is the receptor and the signal
transducer of the most hypotensive hormones, ANF– and B-type natriuretic peptide (BNP).
After binding these hormones at the extracellular domain it, at its intracellular domain,
signals activation of the C-terminal catalytic module and accelerates the production of
cyclic GMP. Cyclic GMP then serves the second messenger role in biological responses
of ANF and BNP such as natriuresis, diuresis, vasorelaxation, and anti-proliferation. Very
recently another modus operandus for ANF-RGC was revealed. Its crux is that ANF-RGC
activity is also regulated by Ca2+. The Ca2+ sensor neurocalcin d mediates this signaling
mechanism. Strikingly, the Ca2+ andANF signalingmechanisms employ separate structural
motifs of ANF-RGC in modulating its core catalytic domain in accelerating the production
of cyclic GMP. In this review the biochemistry and physiology of these mechanisms with
emphasis on cardiovascular regulation will be discussed.
Keywords: atrial natriuretic factor, atrial natriuretic factor receptor guanylate cyclase, calcium, cyclic GMP,
neurocalcin δ, signal transduction
INTRODUCTION
In the 1980s, the ﬁeld of cellular signal transduction underwent
total metamorphosis. Until then only two major paradigms of
signal transduction, that of cyclic AMP and that of IP3 (inosi-
tol triphosphate) were known and were used to explain cellular
signaling mechanisms and the second messenger concepts. Each
of these two paradigms constituted an assemblage of three com-
ponents – receptor, GTP binding protein, and the transducer
catalyst – necessary for signal transduction. The astonishing
discovery of a novel membrane protein that was simultane-
ously a receptor of a hormone and the transducer of its signal
Abbreviations: ANF, atrial natriuretic factor; ANF-RGC, atrial natriuretic factor
receptor guanylate cyclase; ARM, ATP-regulatory module; ATP, adenosine triphos-
phate; BNP, B-type natriuretic peptide; CNP,C-type natriuretic peptide; CNP-RGC,
C-type natriuretic peptide receptor guanylate cyclase; cyclicAMP,3′,5′-cyclic adeno-
sine monophosphate; cyclic GMP, 3′,5′-cyclic guanosine monophosphate; CNG
channel, cyclic nucleotide gated channel; GCAP,guanylate cyclase activating protein;
GC-A, guanylate cyclase-A; GC-B, guanylate cyclase-B; GC-C, guanylate cyclase-C;
GC-D, guanylate cyclase-D; GC-E, guanylate cyclase-E; GC-F, guanylate cyclase-
F; GC-G, guanylate cyclase-G; KHD, kinase homology domain; K-LD, kinase-like
domain; NCδ, neurocalcin δ; NPR-A, natriuretic peptide receptor-A; ONE-GC,
olfactory neuroepithelial guanylate cyclase; STa-RGC, heat-stable enterotoxin (also
guanylin and uroguanylin) receptor guanylate cyclase; ROS-GC, rod outer segment
guanylate cyclase.
added a new dimension to our understanding of cellular sig-
nal transduction. The hormone was the newly described atrial
natriuretic factor (ANF; de Bold, 1985) and the membrane pro-
tein was both its receptor and guanylate cyclase enzyme, termed
therefore atrial natriuretic factor receptor guanylate cyclase (ANF-
RGC; Kuno et al., 1986; Paul, 1986; Paul et al., 1987; Takayanagi
et al., 1987; Meloche et al., 1988). Other terms to describe the
protein are GC-A and NPR-A. ANF-RGC responded to ANF
binding with accelerated synthesis of its second messenger cyclic
GMP. The novelty of the system was 2-fold; ﬁrst, a single pro-
tein, ANF-RGC, which contained both the ability to recognize
the ANF hormonal signal and the activity to translate the hor-
monal information into the production of its second messenger,
cyclic GMP was identiﬁed; and second, cyclic GMP was rec-
ognized as bona ﬁde hormonal second messenger. Until then,
the majority of laboratories forcefully denied the hormonal sec-
ond messenger role of cyclic GMP (reviewed in Sharma, 2002,
2010).
The concept that ANF-RGC is indeed both hormone receptor
and a catalyst was further supported by cloning studies (Chinkers
et al., 1989; Lowe et al., 1989; Pandey and Singh, 1990; Duda
et al., 1991; Marala et al., 1992). Homology cloning made possible
ﬁnding other receptor membrane guanylate cyclases: C-type
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natriuretic peptide receptor guanylate cyclase, CNP-RGC (also
known as GC-B; Chang et al., 1989; Schulz et al., 1989; Duda
et al., 1993b) and heat-stable enterotoxin (also guanylin and
uroguanylin) receptor guanylate cyclase, STa-RGC (GC-C; Schulz
et al., 1990; de Sauvage et al., 1991; Singh et al., 1991; Hamra
et al., 1993; Khare et al., 1994). Identiﬁcation of these three struc-
turally and functionally related membrane guanylate cyclases
that were receptors for hormonally active peptides resulted in
a notion that all membrane guanylate cyclases, even those
still to be discovered, were receptors for speciﬁc extracellular
ligands.
The notion was short-lived, however. The next four, in chrono-
logical order, identiﬁed membrane guanylate cyclases: the rod
outer segment guanylate cyclases, ROS-GC1 (also known as
RetGC1 or GC-E; Koch, 1991; Shyjan et al., 1992; Goraczniak
et al., 1994) and ROS-GC2 (RetGC2 or GC-F; Lowe et al., 1995;
Yang et al., 1995; Goraczniak et al., 1998), the olfactory neuroep-
ithelium guanylate cyclase, ONE-GC (also termed as GC-D) (Fulle
et al., 1995; Duda et al., 2001a) and GC-G (Schulz et al., 1998), did
not respond with increased activity to any extracellular ligand.
They were therefore branded as “orphan receptors” (Fulle et al.,
1995; Yang et al., 1995; Wedel and Garbers, 1997; Schulz et al.,
1998).
ROS-GC1 and ROS-GC2 were not orphan RGC, however. Bio-
chemical and physiological ﬁndings began to reveal that regulation
of their catalytic activities is speciﬁc to their physiological func-
tion which is to return the illuminated photoreceptors to the dark,
resting state. The illumination leads to activation of cyclic GMP
phosphodiesterase, depletion of cyclic GMP, closure of the cyclic
GMP gated (CNG) channels, and lowering the free Ca2+ con-
centration (reviewed in Pugh et al., 1997; Koch et al., 2010). The
ROS-GCs’ task is to restore the dark-level of cyclic GMP allow-
ing opening of the CNG channels and increase of Ca2+ inﬂux.
Ca2+ concentration, thus, determines the activity of ROS-GCs
but it occurs in an indirect way. Guanylate cyclase activating
proteins (GCAPs) sense the post-illumination fall in Ca2+ and
stimulate ROS-GCs to resynthesize cyclic GMP at a faster rate
(reviewed in Detwiler, 2000; Koch et al., 2010). In this cyclic
GMP-Ca2+ feedback mechanism, ROS-GCs do not respond to
an extracellular ligand but to their intracellular Ca2+ sensing lig-
ands, the GCAPs (Palczewski et al., 1994; Dizhoor et al., 1995;
Duda et al., 1996b).
Soon thereafter the evidence began to emerge, primarily from
our laboratory, that GCAPs are not the only Ca2+ sensing modu-
lators of ROS-GC activity. While increasing Ca2+ concentrations
inhibit ROS-GCs activity throughGCAPs, two otherCa2+ sensors,
S100B, and neurocalcin δ (NCδ) stimulate ROS-GC1 in a Ca2+-
dependent fashion (Pozdnyakov et al., 1995; Duda et al., 1996a;
Margulis et al., 1996; Kumar et al., 1999). The Ca2+-dependent
S100B-mediated activation of ROS-GC operates in cones includ-
ing their outer segments and pedicles (Wen et al., 2012). Its role
in photo- and visual transductions remains to be established, but
existing data indicate its involvement in transmission of the visual
signal from cone ON-bipolar cells (Wen et al., 2012). Ca2+ signal-
ing of ROS-GC activity mediated by NCδ is operative in retinal
ganglion cells (Krishnan et al., 2004) but its linkage with the visual
transduction is not clear yet.
Similar, but with additional twists, regulation of ONE-GC
occurs in a subset of olfactory sensory neurons (Fulle et al., 1995;
Duda et al., 2001a; Pertzev et al., 2010). The cyclase was initially
classiﬁed as a member of the Ca2+ modulated subfamily (Duda
et al., 2001a). Its activity is modulated in a Ca2+-dependent fash-
ion by NCδ (Duda et al., 2001a, 2004) and by GCAP1 (Duda et al.,
2006, 2012a; Pertzev et al., 2010). Remarkably, the Ca2+-GCAP1
pattern of ONE-GC modulation is opposite to that of ROS-GC
modulation. Sensing increasing concentrations of Ca2+ GCAP1
stimulates ONE-GC while it inhibits ROS-GC (Duda et al., 2006,
2012a).
After theCa2+-dependentmodulation of ONE-GCactivitywas
demonstrated, an extracellular ligand of the cyclase was found.
The ligand was the odorant uroguanylin (Leinders-Zufall et al.,
2007; Duda and Sharma, 2008; reviewed in Sharma and Duda,
2010; Zufall and Munger, 2010). Hence, ONE-GC responds to
both extracellular (uroguanylin) and intracellular Ca2+ signals.
At this point a new, two-step “cross-talk” odorant transduction
model was proposed (Duda and Sharma, 2009). In “step 1,” the
odorant uroguanylin interacts with the receptor domain of ONE-
GC, causing its minimal activation. The cyclic GMP generated in
response to uroguanylin signal opens a few of the CNG3 channels
leading to some increase in [Ca2+]i in the odorant receptor cell. In
“step 2,” the membrane bound NCδ and GCAP1 sense the increase
in [Ca2+]i and in their Ca2+-bound states fully activate ONE-
GC triggering maximal inﬂux of Ca2+and depolarization of the
olfactory receptor cell membrane.
The odorant receptor ONE-GC linkage with the intracellular
free Ca2+ signals brought forth a question whether this cyclase
is a unique case of dually regulated membrane guanylate cyclase.
Latest studies from our laboratory demonstrate that it is not. The
nascent member of the hormone receptor subfamily, the ANF-
RGC, is also responsive to Ca2+ (Duda et al., 2012a,b) and NCδ is
the sensor protein which communicates the Ca2+ signal to ANF-
RGC and in the Ca2+-bound state, activates ANF-RGC activity.
The two modes of ANF-RGC activation, hormonal and Ca2+-
dependent, engage their speciﬁc and independent pathways of
transmitting the stimulatory signals to the catalytic domain. The
end-product, however, is common, the second messenger cyclic
GMP. Because of the individual signaling mechanisms involved
in Ca2+ and hormonal signaling their net effects are multi-
plicative. Hence, in terms of the original sub-classiﬁcation, the
present day knowledge is that at least two cyclases, ANF-RGC
and ONE-GC, are hybrids sensing both hormonal and Ca2+
signals.
The last cloned membrane guanylate cyclase was GC-G. Until
today, the information of its function is very scarce. It was sug-
gested that the mouse form of GC-G is selectively expressed in the
sperm and may be involved in the process of capacitation (Kuhn
et al., 2004). Other reports suggest that the cyclase is expressed in
Grueneberg ganglion olfactory subsystemwhere it is responding to
CO2 (Chao et al., 2010) or to cool ambient temperature indicating
its role in thermo-sensation (Mamasuew et al., 2008).
The following discussion is exclusively devoted to the ANF-
RGC. It was the ﬁrst template model, which established that
cyclic GMP is a bona ﬁde hormonal second messenger. The ongo-
ing studies deﬁne the second ANF-RGC transduction model,
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Ca2+-modulated signaling. It makes ANF-RGC a bimodal switch,
hormonal and Ca2+. An additional signiﬁcant part of the review is
coverage of themanner inwhich these twomodels have nowbegun
to explain the biochemical principles of cardiovascular, renal and
endocrine homeostasis with special emphasis on blood pressure
regulation.
HORMONAL SIGNALING OF ANF-RGC ACTIVATION
BINDING OF LIGAND-HORMONE ANF
Although intuitively expected, the ﬁrst experimental evidence
that the ANF binding site in ANF-RGC is located within the
extracellular domain came ﬁrst from the site-directed and dele-
tion mutagenesis studies. A mutant ANF-RGC was cloned from
rat adrenal cDNA library (Duda et al., 1991) and termed GCα.
Its sequence differed from ANF-RGC by two amino acid sub-
stitutions Q338 → H and L364 → P which resulted from single
nucleotide mutations, CAG → CAC and CTG → CCG, respec-
tively. Expressed in heterologous system of COS cells, GCα
was properly located in the plasma membrane and exhibited
basal guanylate cyclase activity; it however, neither bound nor
responded toANFor other natriuretic peptides (Duda et al., 1991).
These results demonstrated that the two amino acid substitu-
tions exclusively abolished binding of ANF and therefore ANF
signaling of the cyclase activity. Restoration by site-directed muta-
genesis, glutamine at position 338 and leucine at position 364,
reinstated ANF binding and ANF-dependent stimulation of the
cyclase.
The site of ANF binding was further systematically analyzed
(McNicoll et al., 1992, 1996; He et al., 1995; Misono, 2002). By
cross-linking and proteinase digestion it was determined that the
amino terminus of ANF is in contact with the region M173-F188 of
ANF-RGC, and the C-terminus, with D191-R198 region. The fact
that the identiﬁed contact sites were very close to each other was
interpreted that the N- and C- termini of ANF interface distinct
subunits of ANF-RGC homodimer. Importantly, it also implied
that one ANF-RGC dimer binds one molecule of ANF.
Details of ANF binding to the ANF-RGC extracellular domain
were unraveled by analyses of the extracellular domain of ANF-
RGC co-crystallized with ANF (Ogawa et al., 2003, 2004). These
analyses revealed that (1) the extracellular domain of ANF-RGC
exists as a dimer in the head-to-head conﬁguration; (2) one ANF-
RGC dimer binds one molecule of ANF (2:1 complex); (3) the
binding site in one monomer differs from that in the other - one
monomer binds the N-terminal part of ANF and the other binds
C-terminal part; (4) there is no preference inANFbinding to a spe-
ciﬁc monomer of the extracellular domain; bound ANF occurs in
two alternate orientations of equal occurrence; (5) the membrane-
distal portion of the extracellular domain contains chloride ion
necessary for ANF binding.
TRANSMEMBRANE MIGRATION OF THE ANF BINDING SIGNAL
With the exception of enterotoxin RGC, all membrane guany-
late cyclases contain a hinge region juxtaposed to the N-terminal
side of the transmembrane domain. This region contains two con-
served cysteine residues separated from each other by 6–8 residues.
In ANF-RGC these residues are Cys423 and Cys432 and were indi-
cated as a critical structural motif in ANF signaling (Huo et al.,
1999; Labrecque et al., 1999; Miyagi and Misono, 2000). There
was however no consensus on the mechanism of its operation.
Based on results with intact cells transfectedwithANF-RGCcDNA
it was proposed that the cysteines are involved in dimerization
through the formation of an inter-chain S-S bridge (Huo et al.,
1999; Labrecque et al., 2001) or, that they form an intra-chain
disulﬁde bridge (Huo et al., 1999; Miyagi and Misono, 2000).
Analyses of guanylate cyclase activity in isolated membranes of
COS cell expressing C423S,C432S, andC423S,C432Smutants (Duda
and Sharma, 2005) allowed to conclude that both C423 and C432
residues independently and equally control the catalytic activity
of ANF-RGC and that activation of ANF-RGC does not involve
interchain-disulﬁde bond formation. In the basal state, the disul-
ﬁde motif keeps the ANF-RGC in its repressed catalytic state and
ANF/ATP signaling brings it to the fully active state (Duda and
Sharma, 2005).
A model of hormone-induced rotation has been proposed to
explain how the extracellular signal is transmitted through the
hinge region to the intracellular domain of ANF-RGC (Ogawa
et al., 2004; Misono et al., 2005). Binding of ANF causes a twist
motion of both ANF-RGC monomers centered on a support
point close to the bound ANF. This twist motion translocates the
juxtamembrane domains of both monomers with only minimal
change in the distance between them. Thismovement constitutes a
signal, which is transmitted through the transmembrane domain.
Rotation of the transmembrane domain by 40 degrees occurs in
response to ANF binding (Parat et al., 2010).
PASSAGE OF THE ANF SIGNAL THROUGH THE INTRACELLULAR
DOMAIN
ANF signaling requires ATP
Early studies, before the biochemical characterization of ANF-
RGC, demonstrated that activation by ANF is signiﬁcantly ampli-
ﬁed by ATP in the guanylate cyclase activation (Kurose et al.,
1987; Cole et al., 1989; Chang et al., 1990; Larose et al., 1991;
reviewed in Sharma, 2002; Duda et al., 2005). Subsequently, it
was demonstrated that ATP is obligatory for ANF-dependent acti-
vation of ANF-RGC (Chinkers et al., 1991; Marala et al., 1991;
Goraczniak et al., 1992; Wong et al., 1995; reviewed in Duda
et al., 2005). Because the ATP effect was mimicked by its non-
hydrolyzable analogs, ATPγS and AMP-PNP, it was suggested
that ATP acts as an allosteric regulator (Chinkers et al., 1991;
Marala et al., 1991; Goraczniak et al., 1992; Wong et al., 1995;
reviewed in Duda et al., 2005). Shortly thereafter it was shown
that ATP is also obligatory for the CNP-dependent stimulation of
CNP-RGC (Duda et al., 1993a,b). Thus, it appears that the require-
ment of ATP is a common attribute of natriuretic peptide RGC
signaling.
Studies with ANF-RGC deletion mutants revealed that the ATP
regulated region resides in the intracellular portion of ANF-RGC
between the transmembrane and the C-terminal catalytic domain
(Chinkers and Garbers, 1989; Goraczniak et al., 1992). This region
was named the kinase homology (or kinase-like domain; KHD or
K-LD) because of its sequence similarity with the corresponding
domains of tyrosine kinases (Chinkers et al., 1989; Chinkers and
Garbers, 1989; Duda et al., 1991). A model for the ATP function
was proposed that “binding of ANP to the extracellular domain of
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its receptor initiates a conformational change in the protein K-LD,
resulting in de-repression of guanylate cyclase activity” (Chinkers
and Garbers, 1989). The central idea behind the model was that
KHD in native ANF-RGC suppresses the catalytic module activ-
ity; ANF functions by relieving this suppression. Study from our
group using two KHD deletion mutants, 506–677 and 555–
762, negated this model and proposed an alternative one where
ATP via ATP regulated module (ARM) potentiates the hormonal
signal“(1) the signal is caused by the binding of the hormone to the
receptor site; (2) there is a transmembrane migration of the signal;
(3) the signal is potentiated by ATP at ARM; and (4) the ampliﬁed
signal is ﬁnally transduced at the catalytic site” (Goraczniak et al.,
1992).
ATP allosteric effect and the ARM domain
Within the KHD ANF-RGC contains a sequence, G503-X-G505-X-
X-X-G509 (Goraczniak et al., 1992) which is a modiﬁed form of
the protein kinases’ nucleotide-binding consensus sequence G-X-
G-X-X-G necessary for kinase activity (Wierenga and Hol, 1983;
Hanks et al., 1988; Bratová et al., 2005). This motif was probed
for its signiﬁcance in ATP function in ANF signaling. Through
analyses of a series of deletion and point mutants it was deter-
mined that the G503-X-G505-X-X-X-G509 motif is critical for the
ATP function (Goraczniak et al., 1992; Duda et al., 1993a; Duda
and Sharma, 1995; reviewed in Sharma, 2002; Duda et al., 2005).
Although it is not involved in ATP binding it maintains the steric
arrangements to ﬁt the ATP molecule. For this reason, the motif
has been named ARM (Goraczniak et al., 1992) and the KHD,
where the ARM resides, was termed the ARM domain (Duda
et al., 2001b; Sharma et al., 2001). To get an insight into the mech-
anism of ATP function, the structure of the ARM domain was
simulated through computer-assisted homology based modeling
(Duda et al., 2001b; Sharma et al., 2001; PDB ID 1T53). The basic
structural features of the model have been experimentally val-
idated through point mutation/expression studies (Duda et al.,
2001b; Sharma et al., 2001; reviewed in Sharma, 2002; Duda et al.,
2005).
Spatial determinants of the ARM domain. The domain com-
prises amino acid residues 496–771, which are arranged into two
lobes: the smaller, N-terminal (91 aa residues: 496–586), and the
larger, C-terminal (185 aa residues: 587–771; Duda et al., 2001b).
Four antiparallel β strands and one α helix form the smaller lobe;
the larger lobe is predominantly helical, composed of eight α-
helices and two β strands (Duda et al., 2001b; Sharma et al., 2001).
The ARM motif, G503-X-G505-X-X-X-G509, is located within the
smaller lobe.
The ATP-binding pocket. In order to identify the ARM domain
residues potentially involved in ATP binding the model of this
domain in its ATP-bound form was analyzed (Duda et al., 2005).
A radius of 4 Å from the ATP molecule was chosen as the limiting
distance for the electrostatic, hydrogen or van der Waals’ interac-
tions. Two sets of residues were identiﬁed (Figure 4 in reference
Duda et al., 2005): (1) those forming the ﬂoor of the ATP binding
pocket; (2) those surrounding ATP molecule. The residues in the
ﬁrst set are: G503, R504, G505, S506, N507, Y508, and G509. These
residues have no direct chemical interaction with ATP; they, how-
ever, provide necessary space to accommodate the ATP molecule.
The residues in the second set surround the individual components
of ATP, the adenine ring, the ribose ring and the triphosphate moi-
ety. The adenine ring is surrounded by L511, T513, T514, E515, Q517,
A533, T580, E581, C583, V635, and T645 and L511, T513, and C583 are
within a distance shorter than 3 Å.
G503, L511, T513, T514, G580, S587, D590surround the ribose ring
with L511 andT514 locatedwithin 2.5 Å radius from the ribose. The
phosphate groups are surrounded by R504, G505, L511, K535, N633,
D646, and K535 is the nearest residue (2.6 Å) forming a hydrogen
bondwith the phosphate and has been shown to be critical forATP
regulation of ANF-dependent ANF-RGC activity; D646 interacts
with the triphosphate group of ATP through the formation of a
coordinate bond with the metal ion Mg2+.
Interaction of ATP with the ARM domain. Kinetics of ATP bind-
ing to theARMdomainwas determined throughSPR spectroscopy
(Burczynska et al., 2007). AMP-PNP, the non-hydrolyzable analog
of ATP was used for the binding studies. Half-maximal bind-
ing (EC50) occurred when the concentration of AMP-PNP was
∼0.2mMand the calculatedKD valuewas 0.21mM.Similar results
(EC50 value of 0.15 mM and KD of 0.13 mM) were obtained when
8-azido-ATP was used.
The model-predicted ATP binding pocket (vide supra) was
authenticated experimentally by cross-linking of the puriﬁed iso-
lated ARM domain protein with 8-azido-ATP, trypsin digestion of
the cross-linked product and sequencing of the resulting peptides
(Burczynska et al., 2007). Three peptides were found to be pho-
toafﬁnitymodiﬁed. The longestmodiﬁed peptide was identiﬁed as
G614MLFLHNG-AICSHGNLKSSNCVVDGR639and the shortest
as S631SNC634V635VDGR. In all three peptidesCys634wasmodiﬁed
indicating that this residue was the closest to the azido group. The
G614–R639 fragment contains six ATP-binding pocket-predicted
residues (Duda et al., 2005): S625, K630, S631, S632, N633, and V635;
and the shortest S631–R639 fragment contains three residues: S631,
N633, andV635(Duda et al., 2005). The reﬁned ARM model (Duda
et al., 2005) predicts that V635 is within a 4 Å radius from the
adenine ring; cross-linking of the neighboring residue to C634 val-
idates that these residues are indeed the closest to the C-8 of the
adenine ring.
ATP binding dependent changes in the ARM domain. If ATP
binding to the ARM domain were to serve signaling purposes,
it should induce structural changes that ultimately would signal
activation of the catalytic domain. Comparative analyses of the
ARM domain models in the apo and ATP-bound states identiﬁed
such changes. They involve rotations of the β strands within the
smaller lobe as well as movements of the β strands and α helices in
the larger lobe (Duda et al., 2001b; Sharma et al., 2001; reviewed
in Duda et al., 2005). Consequences of two such changes appear
to be of particular importance: ﬁrst, of the β1, β2 strands in the
smaller lobe, and the second, of the EF and F helices in the larger
lobe.
The β1 and β2 strands and the loop connecting them encom-
passes the G503-X-G505-X-X-X-G509 motif (Duda et al., 2001b;
Sharma et al., 2001; reviewed inDuda et al., 2005),which ismeshed
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in and ﬂanked by six phosphorylation sites, S497, T500, S502, S506,
S510, T513 (Potter and Hunter, 1998a, 1999a). The present con-
sensus is that “phosphorylation of KHD is absolutely required for
hormone-dependent activation of NPR-A” (Potter and Hunter,
1998a,b, 1999b). In this concept, hypothetical protein kinase and
protein phosphatase co-exist with ANF-RGC (Foster and Garbers,
1998). Until now, however, neither the kinase nor the phosphatase
has been identiﬁed.
Comparison of the ATP-free and ATP-bound ARM domain
models allows explaining how ATP binding makes it possible for
the serine and threonine residues to undergo phosphorylation.
After ATP binds to the ARM domain, the β1, β2 strands, and the
loop between them shift by ∼3–4 Å and rotate by ∼15◦ (Duda
et al., 2001b; Sharma et al., 2001; reviewed in Duda et al., 2005).
This movement triggers reorientation of the serine and threonine
residues (Figure 1, red colored residues) causing the side chains
and the OH groups of T500, S502, S506, and T513 becoming directed
toward the protein surface (Figure 1, compare the positions of the
cyan- and red-colored OH groups). The change in the positions
of the side chains is most drastic for the S502 and S506 residues.
Although upon ATP binding there is no toward the surface reori-
entation of the S497 and S510 OH groups, the entire residues are
shifted toward the surface (Figure 1). This structural rearrange-
ment permits the hypothetical protein kinase to access the side
chains of the residues and transfer the phosphate group (Duda
et al., 2011).
Another important result of ATP binding on the dynamics
within the ARM domain is the translocation within the larger
lobe of two helices, EF and F. Their movement was character-
ized by analyzing the ATP-dependent changes in the ﬂuorescence
intensity and wavelength of two tryptophan residues W601 and
W669 (Duda et al., 2009). Both residues reside in the larger lobe
of the ARM domain, outside the ATP-binding pocket. The W601
residue is a part of the helix E structure (Duda et al., 2001b, 2005),
its side-chain is oriented toward the protein surface, and it is
ﬂanked by several hydrophobic residues, F640, L607, S606, and S596
(Figure 2A). These structural features deﬁne the ﬂuorescenceλmax
of W601 at 332 nm. W669 residue is located at the end of a loop
FIGURE 1 | ATP binding to the ARM domain affects the conformation
of the six phosphorylable residues. The conformation of the six
phosphorylated residues is shown before (cyan) and after (red) ATP binding.
The ATP molecule is shown in green. The positions of the OH groups are
indicated by cyan and red balls (reproduced with permission from ref. Duda
et al., 2011).
connecting β8 strand and EF helix (Duda et al., 2009); it is a part of
a conserved hydrophobic motif, 669WTAPELL675. The side chain
of W669 is ﬂanked by the polar residues: E699, S631, K667, K630,
and L696 (Figure 2B). This environment causes red shifts in the
ﬂuorescence λmax of W669 to 345 nm.
Superimposition of the ATP-free and the ATP-bound forms
indicates that ATP binding induces contraction of the entire ARM
domain and affects the orientation and environment of W669. The
contraction results in shortening of the distance betweenW669and
the ATP binding pocket (Figure 2C). ATP binding also causes
reorientation of the W669 side chain. It turns and becomes more
shielded by the surrounding amino acids. Turning of the W669
side chain pushes the remainder of the motif, 670TAPELL675, to
the surface resulting in its exposure. In general, the movement of
a hydrophobic motif toward the surface of the protein indicates
its readiness for interaction. For the 669WTAPELL675 motif it was
proposed that it interacts with subsequent transduction motif,
possibly within the catalytic domain, propagates the ANF/ATP
binding signal and activates the catalytic domain (Duda et al.,
2009).
Based on the studies narrated above a model for ANF/ATP
signaling of ANF-RGC activity was proposed: The ANF signal
originates by the binding of one molecule of ANF to the extracel-
lular dimer domain of ANF-RGC (Ogawa et al., 2004, 2009). The
binding modiﬁes the juxtamembrane region where the disulﬁde
423Cys-Cys432 structural motif is a key element in this modiﬁca-
tion (Ogawa et al., 2004,2009; Duda and Sharma,2005). The signal
twists the transmembrane domain (Parat et al., 2010), induces a
structural change in the ARM domain, and prepares it for the
ATP activation. ARM domain binds ATP to its pocket what leads
to a cascade of temporal and spatial changes (Duda et al., 2001b;
Sharma et al., 2001; reviewed in Duda et al., 2005). They result
in (1) exposure of the hydrophobic 669WTAPELL675 motif which
directly (or indirectly) interacts with the catalytic domain causing
its partial activation; and (2) exposure and phosphorylation of six
serine, threonine residues and full activation of ANF-RGC. Con-
comitantly, phosphorylation converts ATP binding site from the
high to low afﬁnity, ATP dissociates and ANF-RGC returns to its
ground state (Duda et al., 2011).
CATALYTIC DOMAIN
When more then 20 years ago an ANF RGC was puriﬁed to
homogeneity and shown to contain the ANF binding and cyclic
GMP forming activities on the same protein chain, the authors
proposed a topological model for the transmembrane receptor
enzyme in which the receptor part was extracellular and the
cyclase catalytic domain was intracellular (Sharma et al., 1988a,b).
The cloning studies conﬁrmed this prediction. Alignment of the
deduced amino acid sequences of the cloned guanylate cyclases
indicated that the catalytic domain is located at the C-terminus of
ANF-RGC and comprises 239 amino acid residues (Chinkers et al.,
1989; Duda et al., 1991). This prediction was tested experimentally
(Thorpe and Morkin, 1990; Thorpe et al., 1996). The carboxy ter-
minal 293 amino acids fragment of ANF-RGC was expressed as
a soluble protein and shown to exhibit guanylate cyclase activ-
ity. These results were in agreement with studies that determined
through radiation inactivation experiments that the ANF-RGC
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FIGURE 2 | (A) Amino acid residues surrounding W601 and (B) amino
acid residues surrounding W669 within the ARM domain. Amino acid
residues depicted in red are located within a 4 Å sphere from the
respective tryptophan residue (green). (C) Conformational changes within
the 669WTAPELL675 motif induced by ATP binding to the ARM domain.
The backbone structure of the ATP-bound ARM domain is shown in cyan
and the ATP molecule is in green. The 669WTAPELL675 motif is shown in
magenta color. Apo structure of the ARM domain was superimposed on
the ATP-bound form to assess the relative, ATP binding induced,
conformational changes. For clarity, only the 669WTAPELL675 motif
(shown in red) of the apo-enzyme is visible. ATP binding results in a
more compact structure of the ARM domain: the W669 side chain moves
toward the ATP binding pocket while the side chains of T670, E673, L674,
and L675 move toward the protein surface [compare the orientation of
side chain of these amino acid residues before (in red) and after (in
magenta) ATP binding; fonts for W669 and L675 residues are increased for
better visibility]. This movement changes the surface properties of the
ARM domain. The movement toward the surface of the protein is poised
to facilitate interaction of this amino acid stretch with subsequent
transduction motif, possibly within the catalytic domain, propagation of
the ANF/ATP binding signal and activation of the catalytic domain
(reproduced with permission from ref. Duda et al., 2009).
fragment containing cyclase activity has a molecular weight of
32 ± 8 kDa (Tremblay et al., 1991). Further studies identiﬁed sev-
eral residues within this region that appeared to be critical for
the guanylate cyclase activity: L817 (Miao et al., 1995), D877, K887,
D893, G900, H909, R940, and H944 (Thompson and Garbers, 1995).
Their individual mutations to Ala resulted in ANF-RGC mutants
without detectable guanylate cyclase activity. In contrast to these
residues, mutation of E974 to Ala resulted in a hyperactive ANF-
RGC mutant (Wedel et al., 1997). Based on these results it was
concluded that the indicated residues are located within or close
to the catalytic center or are critical for the proper folding of the
catalytic center.
In the absence of a crystal structure of any membrane guany-
late cyclase catalytic domain a model of the catalytic center of
retGC-1, a mammalian membrane guanylate cyclase expressed
in the retina, also known as ROS-GC1 was proposed (Liu et al.,
1997). The model was built based on homology with the catalytic
center of the adenylate cyclase. The modeling studies allowed
identiﬁcation of the critical residues constituting the catalytic
core. Because the catalytic domains of all membrane guany-
late cyclases are highly conserved (>95% of sequence identity),
by homology substitution, the critical residues of the ANF-
RGC catalytic center have been identiﬁed and they are described
below.
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The catalytic center is homodimeric. There are two GTP bind-
ing sites. Each GTP molecule interacts with both monomers. In
the following description of the ANF-RGC catalytic center the
monomers are labeled“A”and“B”and the location of each residue
within a monomer A or B is indicated. Numbering of amino acids
is according to the mature protein (Duda et al., 1991). R959(B) and
C961(B) interact with guanine’s O6; second NH2 group of R959(B)
interacts with guanine’s N1; the carboxy group of E889(B) interacts
with R959(B) and through it with N1; G964(B) interacts with N7;
T854(A), D893(A) and N968(B) form hydrogen bonds with ribose’s
OH (3′) group; R972(B binds α phosphate group; R940(A) binds
β phosphate group; E974(A) through Mg2+ interacts with β phos-
phate group; and S971(A) binds γ phosphate group. Speciﬁcity
toward GTP is determined by E889 and C961 of ANF-RGC. This
conclusion is drawn based on studies showing that in ROS-GC1
mutation of the corresponding E to K and C to D converts guany-
late cyclase activity into adenylate cyclase activity (Tucker et al.,
1998).
Mechanism of ANF-RGC activation – the role of the 669WTAPELL675
motif
An important feature of the model of ANF/ATP-dependent acti-
vation of ANF-RGC is the relay function of the 669WTAPELL675
motif. It switches between the ATP-bound ARM domain and acti-
vates the catalytic domain. It was proposed that thismotif interacts
with and signals the antiparallel homo-dimer of the catalytic
domain to undergo conformational changes and form a func-
tional catalytic center (Duda et al., 2009). The exact site within
the catalytic domain which is targeted by the 669WTAPELL675
motif remains to be determined. Preliminary scanning experi-
ments, however, suggest that the site may be located close to the
E889, a residue critical for cyclase speciﬁcity toward GTP (Tucker
et al., 1998).
If the elements of themodel are correct and the 669WTAPELL675
motif is a switch, its deletion from the ANF-RGC should lead to
a protein which binds ANF and ATP but is not able to respond
to them with increased synthesis of cyclic GMP. This assumption
was tested experimentally. An ANF-RGC mutant was created in
which the 669WTAPELL675 motif was deleted bymutagenesis.Wild
type ANF-RGC and the mutant were expressed individually in
COS cells and their membranes were analyzed (1) by Western
blot to determine the proteins’ levels of expression; (2) for basal
guanylate cyclase activity; (3) for ANF binding; and (4) for KM
for the substrate GTP. The results demonstrated that (1) the wild
type ANF-RGC and the 669WTAPELL675 deletion mutant were
expressed to the same level as determined by Western blot; (2) the
basal cyclase activity of the mutant, 20 pmol cGMP min−1 (mg
protein)−1, was virtually identical to that of the wild type ANF-
RGC, 21 pmol cGMP min−1 (mg protein) −1; (3) their receptor
activities were equal with the respective speciﬁc binding values
of 9.7 ± 0.6 and 10.1 ± 0.9 pmol [125I]ANF/mg protein and (4)
the KM values for the substrate GTP, 614 μM for the wild type
and 608 μM for the mutant protein were identical. Thus, the basal
integrity of the protein remained intact despite the deletion (Duda
et al., 2009).
When the mutant was exposed to increasing concentrations of
ANF and ATP its cyclase activity remained practically unchanged
whereas under identical conditions wild type ANF-RGC was stim-
ulated over 6-fold (Duda et al., 2009, 2013) demonstrating that
in line with the original expectations the catalytic domain does
not increase cyclic GMP synthesis in the presence of ANF/ATP.
This type of outcome could only be observed if the mutant pro-
tein did not bind ANF and/or ATP or the catalytic domain lost
its cyclase ability. Both of these possibilities were put to rest as
the mutant and the wild type cyclase did not differ in ANF and
ATP binding nor in enzymatic activity (vide supra and ref. Duda
et al., 2009). Therefore the only explanation for the unchanged
level of cyclic GMP synthesis is that the 669WTAPELL675 deletion
mutant is not able to respond to ANF and ATP. This leads to just
one logical conclusion that in the absence of the 669WTAPELL675
motif the ANF/ATP binding information is not transmitted to
the catalytic domain. Thus, the 669WTAPELL675 motif is the
critical transmitter of the ATP-potentiated ANF signal to the
catalytic domain where it is translated into generation of cyclic
GMP.
Ca2+ SIGNALING OF ANF-RGC ACTIVITY
NEURONAL CALCIUM SENSOR NEUROCALCIN δ
Neurocalcin δ belongs to a distinct subfamily of neuronal calcium
sensor proteins (NCS) together with visinin-like proteins (VILIPs)
and hippocalcin. They all are acylated at the N-terminus by myris-
tic acid and undergo a classical calcium-myristoyl switch (Ladant,
1995), e.g., they bury the myristoyl group in a hydrophobic pocket
in Ca2+−free form and expose it in Ca2+-bound form, as ﬁrst
observed and described for recoverin (Zozulya and Stryer, 1992).
Exposure of myristoyl group enables the protein association with
the cell membrane. However, once it binds, in a Ca2+-dependent
fashion, to the membrane phospholipids, even after removing
Ca2+ by the addition of EGTApart of it remainsmembrane bound
(Krishnan et al., 2004). Although NCδ is primarily expressed in
neuronal tissues, its expression in the periphery is also observed.
Functionally, NCδ has been linked to receptor endocytosis
through interaction with α- and β-clathrin and β-adaptin (Ivings
et al., 2002), trafﬁcking and membrane delivery of glutamate
receptors of the kainate type (Coussen and Mulle, 2006), and due
to its Ca2+-dependent afﬁnity for S100B protein and tubulin β-
chain (Okazaki et al., 1995), withmicrotubule assembly (Iino et al.,
1995). In the sensory and sensory-linked neurons, the presence of
NCδ has been found in the inner plexiform layer of the retina, e.g.,
in the amacrine and ganglion cells (Krishnan et al., 2004), olfac-
tory sensory neurons (Duda et al., 2001a, 2004) and recently, it has
been identiﬁed in type II cells of mouse circumvallate taste papil-
lae, indicating its possible role in gustatory transduction (Rebello
et al., 2011).
A relatively newly identiﬁed function of NCδ is its Ca2+-
dependent modulation of the activities of membrane guanylate
cyclases ROS-GC1 in the retina and ONE-GC, in the olfactory
neuroepithelium (Duda et al., 2001b, 2004; Krishnan et al., 2004).
In these tissues NCδ co-localizes with its respective target cyclases.
The exact physiological signiﬁcance of the ROS-GC1- NCδ sig-
naling system in the retinal neurons is not known yet. It can be,
however, safely stated that the pathway is not present in the rod and
cone outer segments, thus is not linked with the phototransduc-
tion machinery. The system has been localized to the lower strata
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of the inner plexiform layer and to a subpopulation of ganglion
cells (Krishnan et al., 2004).
In the olfactory neuroepithelium NCδ serves as a Ca2+ sen-
sor component of the two-step odorant uroguanylin signaling
machinery. This signalingmechanismwas proposed to be initiated
by uroguanylin interaction with the extracellular receptor domain
of ONE-GC (Leinders-Zufall et al., 2007; Duda and Sharma, 2008;
reviewed in Zufall and Munger, 2010; Sharma and Duda, 2010).
This interaction leads to partial activation of ONE-GC, gener-
ation of small amount of cyclic GMP, partial opening of cyclic
GMP-gated channel and inﬂux of Ca2+ into the olfactory recep-
tor neuron. In the next step, Ca2+ binds to NCδ which, then fully
activates ONE-GC (Duda and Sharma, 2009).
FREE Ca2+ SIGNALS ANF-RGC ACTIVATION
In the course of mapping the NCδ targeted site on ROS-GC1
to which it binds and transmits the Ca2+ signal to the cat-
alytic domain for signal translation into the generation of cyclic
GMP, our group made a remarkable observation that NCδ binds
directly to the catalytic domain and, thereby, activates ROS-GC1
(Venkataraman et al., 2008). Protein database comparison shows
sequence conservation of the catalytic domain in the membrane
guanylate cyclase family hinting at a possibility that other mem-
brane guanylate cyclases might be activated by Ca2+ via NCδ
as well. To test this possibility, ANF-RGC membrane guanylate
cyclase, for which the only established signal transduction mecha-
nism was throughANF/ATP (vide supra), was chosen. And indeed,
in a recombinant system,myristoylatedNCδ stimulatedANF-RGC
activity in a dose- and Ca2+-dependent manner; 0.5 μM Ca2+
and 0.5 μM NCδ triggered half-maximal activation of ANF-RGC
(Duda et al., 2012a,b). These results for the ﬁrst time demonstrated
that ANF-RGC activity is dually regulated, by peptide hormones
ANF and BNP, and by Ca2+, thus, at least in vitro the cyclase was
deemed a bimodal signal transducer.
Myristoylated dimeric form of neurocalcin δ is the transmitter of the
Ca2+ signal
Since NCδ belongs to the family of NCS and myristoylation at
N-terminus is a characteristic feature of a majority, but not all, of
these proteins important for their cellular function, it was nec-
essary to check whether myristoylation was required for NCδ
to transmit the Ca2+ signal for ANF-RGC activation. Reconsti-
tution experiments of ANF-RGC with both myristoylated and
non-myristoylated NCδ showed that only the myristoylated NCδ
stimulated the cyclase activitywhereas thenon-myristoylated form
was ineffectual (Duda et al., 2012b). Importantly, both forms
exhibited comparable afﬁnity for ANF-RGC. In addition to acti-
vating ANF-RGC myristoylated NCδ also lowered the cyclase’s KM
for substrate GTP and increased its catalytic efﬁciency, kcat, from
6.5 ± 0.3 to 41.4 ± 0.5 pmol cyclic GMP/s.
The biochemical and homology based modeling studies indi-
cate that the secondary structure of the functional form of all
membrane guanylate cyclases is homodimeric (Rondeau et al.,
1995; Liu et al., 1997; Venkataraman et al., 2008). The contact
points for their homo-dimeric formation reside in their extracel-
lular domain (Misono et al., 2011) and in the intracellular domain
within the highly conserved dimerization domain (Wilson and
Chinkers, 1995) and core catalytic core domain (Venkataraman
et al., 2008). The X-ray crystallographic studies have demon-
strated that NCδ also exists as a dimer (Vijay-Kumar and Kumar,
1999). Thus, it was reasonable to expect that the Ca2+-modulated
functional unit is NCδ dimer and ANF-RGC dimer.
This expectation was validated experimentally. When
monomeric and dimeric forms of myristoylated NCδ were indi-
vidually tested in reconstitution experiments for their abilities to
stimulate ANF-RGC catalytic activity only the dimer was effec-
tive (Duda et al., 2012b). The stimulation by the monomeric form
was only marginal, possibly resulting from spontaneous dimer-
ization of the monomers when higher NCδ concentrations were
used (Duda et al., 2012b). Thus indeed the functional Ca2+ sig-
nal transduction unit is composed of one NCδ dimer and one
ANF-RGC dimer.
Neurocalcin δ targets directly the catalytic domain of ANF-RGC
The ANF-RGC fragment, aa 788–1029, encompassing the core
catalytic domain, I820–G1029, was expressed as a soluble protein
and tested for its basal and Ca2+-dependent modulated via NCδ
activities. The protein exhibited intrinsic guanylate cyclase activity
(18 ± 4 pmol cyclic GMP min−1 mg protein−1). This activity
increased when Ca2+ and NCδ were added, and the increase was
Ca2+ and NCδ-dose dependent (Duda et al., 2012b). Interestingly,
the estimated EC50 for NCδ was comparable to that determined
for full-length ANF-RGC strongly supporting the expectation that
the NCδ signaling site resides within the catalytic domain.
The NCδ targeted site on ROS-GC1 was mapped to the
aa segment V837–L858. The corresponding site on ANF-RGC,
849DIVGFTALSAESTPMQVVTLLMQ871, has 70% sequence con-
servation in comparisonwithROS-GC1.When a synthetic peptide
of this sequence was used in a functional interference experiment
almost complete inhibition of the NCδ-stimulated ANF-RGC
activity at 200 μM with an IC50 value of 80 μM was observed
(Duda et al., 2012b). Because a scrambled peptide did not exhibit
any inhibitory effect it was justiﬁed to conclude that theANF-RGC
region 849DIVGFTALSAESTPMQVVTLLMQ871 mediates NCδ-
dependent Ca2+ stimulation of ANF-RGC activity. This region
is a part of the core catalytic domain and common to the cor-
responding sites in other membrane guanylate cyclases28, it has
a secondary structure of helix-loop-helix and is acidic in nature
with a pI of 3.37 (Duda et al., 2012b).
The effects of ANF/ATP and Ca2+-neurocalcin δ signaling of
ANF-RGC activity are multiplicative
To determine the liaison between ANF/ATP and Ca2+-NCδ sig-
nalingmodes,ANF-RGC activity was analyzed ﬁrst in the presence
of 1 μM Ca2+ and 2 μM myristoylated NCδ and then with
increasing concentrations, ranging from 10−11 M to 10−6 M,
of ANF and constant 0.8 mM ATP. The presence of Ca2+ and
NCδ resulted in stimulation of the cyclase activity approx. 3.5-
fold above the basal activity. Addition of ANF and ATP resulted in
additional 4.5-fold stimulation, demonstrating that theCa2+-NCδ
and ANF/ATP effects are multiplicative (Duda et al., 2012b). It is
noteworthy that in the absence of Ca2+ in the reaction mixture
only the ANF/ATP-dependent stimulation of ANF-RGC activity
was observed.
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The preceding narration on the mechanisms involved in the
hormone- or Ca2+-NCδ-dependent stimulation of ANF-RGC
activity explains the independence and multiplicativeness of the
ANF and Ca2+-NCδ signals in the activation of ANF-RGC. It
is based on our evolving conceptual scheme whose central idea
is that the functional speciﬁcity of a guanylate cyclase is deter-
mined by the structure of its modular blocks. The structural
motif, 669WTAPELL675 is involved in transmitting the ANF signal
to the catalytic domain (Duda et al., 2009) but it is not involved in
transmitting the Ca2+ signal to the catalytic domain; instead the
849DIVGFTALSAESTPMQVVTLLMQ871 motif is involved (Duda
et al., 2012b).
PHYSIOLOGICAL VALIDATION OF THE TWO SIGNALING
MECHANISMS OF THE ANF-RGC ACTIVATION
The two described above signaling mechanisms of ANF-RGC acti-
vation are depicted in Figure 3. It is obvious from their description
that they were developed based solely on biochemical obser-
vations. And although biochemically well-proven, they would
have to be considered only hypothetical until their validity was
conﬁrmed in vivo. And this validation is narrated below.
SIGNALING THROUGH THE 669WTAPELL675 MOTIF
In an in vitro reconstituted system the 669WTAPELL675 motif is
critical for the transmission of the ANF/ATP signal and activa-
tion of the ANF-RGC catalytic domain and its absence results in
unresponsiveness of the mutated ANF-RGC to the signal so if the
same happens in vivo, an animal model in which the sequence
coding for the 669WTAPELL675 motif is deleted from the ANF-
RGC gene should be unresponsive to ANF and therefore exhibit
all physiological consequences of this unresponsiveness. Following
this logic, the 669WTAPELL675 sequence was deleted in genetically
altered mice (Duda et al., 2013). It is worth mentioning that up till
now it is the only ANF-RGC domain-speciﬁc genetically modiﬁed
animal model.
In agreement with the in vitro determinations, basal
ANF-RGC activity in the membranes of the heart, adrenal
gland and kidney, the primary tissues where ANF-RGC
is expressed, was practically indistinguishable between the
wild type control (ANF-RGC669WTAPELL675+/+), heterozy-
gous (ANF-RGC669WTAPELL675+/−) and homozygous (ANF-
RGC669WTAPELL675−/−) mice (Duda et al., 2013). However, the
mutated cyclase expressed in these tissues did not respond to
ANF/ATP stimulation. The cyclase activity in the membranes of
the homozygous mice was the same when assayed in the presence
of 10−7 MANF and 0.8 mMATP as when assayed in their absence.
Interestingly, for the heterozygous mice, the cyclase remained
responsive to ANF/ATP but the maximal achieved activity oscil-
lated around 50% of the wild type values, clearly showing that in
the heterozygous mice where the product of one ANF-RGC gene
copy is of the wild type and the other, of the deletion-mutated
cyclase, only the wild type ANF-RGC is responsive to ANF/ATP
FIGURE 3 | (A)Topography of ANF-RGC. The dashed lines on the right show
the boundaries of: LS, leader sequence; ExtD, extracellular domain; TM,
transmembrane domain; ICD, intracellular domain. The functional domains in
ICD, their names and the aa constituting their boundaries are indicated at the
left: JMD, juxtamembrane domain; ARM, the ATP regulated module;
SHD-signaling helix domain; CCD-core catalytic domain. The site targeted by
NCδ (encircled) is within CCD. (B)The signaling pathways of ANF and of NCδ
are independent. The trajectory of the ANF pathway is in red dashed arrow.
From the ExtD, it passes through theTM, ARM and SHD in its course to CCD.
The trajectory of the NCδ pathway (in blue dashed arrow) is within the CCD.
The CCD exists as an antiparallel homodimer (reproduced with permission
from ref. Duda et al., 2012b).
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and the mutant is not (Duda et al., 2013). Thus, the in vitro activity
characteristics were the mirror images of these in vivo.
Almost identical values of basal guanylate cyclase activity in
various tissues of the 669WTAPELL675 targeted mice and their iso-
genic controls implied that the expression of the mutant-cyclase
must not differ from the expression of the wild type cyclase. This
implication was conﬁrmed by the results of immunocytochemical
analyses. Side-by-side immunostaining with immunopuriﬁed anti
ANF-RGC antibody resulted in identical images of the kidneys and
adrenal glands of the wild type, heterozygous and homozygous
669WTAPELL675 targeted mice. Also, visual examination of the
stained sections as well as of the respective differential interference
contrast images indicated that the targeting of the 669WTAPELL675
motif does not change the integrity of these tissues (Duda et al.,
2013).
The main function of ANF/ANF-RGC signaling system is to
regulate natriuresis, diuresis, vasodilation, and prevent cardiac
and renal hypertrophy. It regulates blood volume homeostasis and
blood pressure by off-setting the renin-angiotensin-aldosterone
system (RAAS): inhibiting renal renin secretion and aldosterone
synthesis in the adrenocortical zona glomerulosa (Burnett et al.,
1984; Brenner et al., 1990; Maack, 1996; Olson et al., 1998; Aoki
et al., 2000; Shi et al., 2001). Therefore, elimination of ANF-RGC
signaling through knocking-out either ANF-RGC or ANF gene
leads to increased blood pressure, cardiac, and renal hypertro-
phy, ﬁbrosis, to name some of the related pathological conditions
(Dubois et al., 2000; Kishimoto et al., 2001; Ellmers et al., 2007;
Das et al., 2010; Ellis et al., 2011; Pandey, 2011; Wadei and Tex-
tor, 2012). Since the 669WTAPELL675 targeted mice have partially
(heterozygous) and fully (homozygous) suppressed ANF-RGC
response to ANF, but the basal cyclase activity is unaffected the
critical question was: does this suppression lead to increased blood
pressure and other physiological alterations in the genetically
modiﬁed mice?
The answer obtained was clearly “yes.” In comparison with the
wild type the blood pressure of the heterozygousmice increased by
∼37% and of the homozygous mice by ∼56%. The increase was
statistically highly signiﬁcant with P value < 0.005 (Duda et al.,
2013). It rose from 102 ± 9 mm Hg for the wild type mice to
134 ± 17 mm Hg for the heterozygous and 159 ± 11 mm Hg for
the homozygous mice. These values showed that the progressive
elevation of blood pressure directly correlates with the number of
mutated ANF-RGC gene copies.
Because volume homeostasis and blood pressure are inﬂuenced
by the mineralocorticoid hormone aldosterone secreted by the
cells of the adrenocortical zona glomerulosa and the function of
the ANF/ANF-RGC system is to inhibit this synthesis the obvi-
ous next question was whether the increased blood pressure in
the 669WTAPELL675 targeted mice is a consequence of the inabil-
ity of the mutated ANF-RGC to transduce the ANF signal and to
synthesize cyclic GMP sufﬁcient quantities to inhibit aldosterone
synthesis? A hint was provided by studies on ANF-RGC knock-
out mice showing that these mice had increased aldosterone level
(Zhao et al., 2007).
The plasma aldosterone concentrations were measured in
both types of genetically modiﬁed mice (hetero- and homozy-
gous) and in their isogenic controls (wild type). The results
demonstrated that, in comparison with the wild type mice, the
plasma aldosterone concentration increased by approximately
40% (from 147 ± 12 to 204 ± 18 pg/ml) in the plasma of the
heterozygous mice (P < 0.005) and by approximately 75% (up to
256±22pg/ml) in theplasmaof thehomozygousmice (P <0.005)
(Duda et al., 2013).
Chronic pressure overload is almost always accompanied by
cardiac hypertrophy (reviewed in Katholi and Couri, 2011). The
same is observed in the 669WTAPELL675 targeted mice. The ratio
of the heart weight (in mg) to whole body weight (in g) mea-
sured in 12 weeks old mice was 5.6 ± 0.3 and 6.1 ± 0.5 for the
669WTAPELL675(+/−) and 669WTAPELL675(−/−) mice, respec-
tively, whereas it was 5 ± 0.3 for the wild type mice (Duda et al.,
2013). However, hypertension is not the only cause of myocar-
dial hypertrophy. Using animal models it has been shown that
antihypertensive drugs do not always ameliorate cardiac hyper-
trophy (Knowles et al., 2001) and that even without systemic
hypertension cardiac hypertrophy may occur (Oliver et al., 1997;
Holtwick et al., 2003). Because deletion of the 669WTAPELL675
motif fromANF-RGC results in decreased synthesis of cyclic GMP
it was hypothesized that cardiomyocytes of the 669WTAPELL675
targeted mice succumb to the insufﬁcient quantities of cyclic
GMP and normal inhibition of myocardial proliferative responses
does not occur. Our ongoing studies indicate that indeed it
is the case. The mice as young as 3 weeks of age (at wean-
ing) exhibit signiﬁcant cardiac hypertrophy. Which cyclic GMP-
dependent signaling pathway involved in inhibition of myocardial
proliferative responses is affected in these mice remains to be
determined.
Taken together the biochemical and physiological evidence
prove that the 669WTAPELL675 motif is critical for the ANF-RGC
function as the transducer of the ANF/ATP signal.
NEUROCALCIN δ Ca2+-DEPENDENT SIGNALING OF ANF-RGC
To demonstrate that theANF-RGCNCδ-Ca2+ signal transduction
system is functional in vivo a mouse model with a disrupted NCδ
gene was constructed and analyzed. Unfortunately, disruption of
both copies of NCδ gene is lethal. Although it was unexpected at
the time of developing the mouse line, it can be now understood
in view of the results demonstrating that NCδ may be involved
in spermatogenesis. Therefore, heterozygous, NCδ+/−, line is
viable.
Because earlier studies from our laboratory and others’ had
shown that NCδ is expressed in the adrenocortical zona glomeru-
losa (Nakano et al., 1993; Duda et al., 2012a) and that the adrenal
gland also contains functional ANF-RGC transduction system
(Takayanagi et al., 1987; Sharma et al., 1989; Duda et al., 1991;
Rondeau et al., 1995) the adrenal gland appeared to be the tissue of
choice for testing whether the ANF-RGC NCδ-Ca2+ signal trans-
duction system is operational and of physiological signiﬁcance
there.
To show that NCδ is indeed the Ca2+-sensor modulator of
ANF-RGC in the adrenal gland the particulate fractions of the
adrenal glands from wild type and NCδ+/− mice and their iso-
genic controls (NCδ+/+) were tested for guanylate cyclase activity
in the presence and absence of Ca2+. The activity in membranes
isolated in the absence of Ca2+ was about 66 pmol cyclic GMP
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min−1 (mg protein) −1 for the control and NCδ+/− mice and
the activity was not affected by the presence or absence of Ca2+
in the assay mixture. However, the activity in membranes iso-
lated in the presence of Ca2+ was strongly dependent on the
mice genotype and Ca2+ in the assay mixture. When assessed
in the absence of Ca2+, the activity was ∼70 pmol cyclic GMP
min−1 (mg protein) −1 for the weight and NCδ+/− mice but
when assessed in the presence of 1 μM Ca2+ the activity was
223 ± 20 pmol cyclic GMP min−1 (mg protein) −1 for the
wild type mice and 135 ± 10 pmol cyclic GMP min−1 (mg
protein) −1 for the NCδ+/− mice. Thus, the Ca2+-dependent
NCδ-modulated ANF-RGC signaling pathway in the mice with
one copy of NCδ gene deleted (NCδ+/−) is functionally half as
active as in the wild type mice. To further authenticate that the
lowering of the Ca2+-dependent cyclase activity in the adrenal
gland membranes of NCδ+/− mice is the exclusive consequence
of lower NCδ expression, 2 μM exogenous NCδ was added to
the NCδ+/+ and NCδ+/− membranes (isolated in the presence
of Ca2+) and the cyclase activity was determined in the presence
of 1 μM Ca2+. The cyclase activity in the NCδ+/+ adrenal mem-
branes increased only minimally, from 220 to 279 ± 21 pmol cyclic
GMP min−1 (mg protein) −1 but in the NCδ+/− membranes, the
increase was signiﬁcantly larger, from 133 to 284 ± 24 (Duda
et al., 2012b). Thus, the activity achieved was practically the same
for both types of membranes. Hence, addition of exogenous NCδ
to the NCδ+/− adrenal gland membranes restores the guanylate
cyclase activity and brings it to the level of activity in the NCδ+/+
membranes. We rationalized that the slight activity increase in the
NCδ+/+ membranes observed upon addition of exogenous NCδ
is caused by a partial loss of the native NCδ during the membrane
preparation.
What is the function of this pathway in the adrenal gland?
In general, the primary role of ANF-RGC in the adrenal gland
is to offset the renin-angiotensin system and inhibit aldos-
terone synthesis, and by doing this, to lower blood pressure
(Burnett et al., 1984; Aoki et al., 2000; Shi et al., 2001). There-
fore, is the Ca2+-dependent ANF-RGC signal transduction
machinery in the adrenal gland involved in aldosterone syn-
thesis? Our ongoing studies indicate that indeed it is. The
plasma aldosterone levels in the NCδ+/− mice are approxi-
mately 27% higher than in the plasma of the control (NCδ+/+)
mice. And the effect is exclusive for the aldosterone synthe-
sizing glomerulosa cells, because corticosterone (synthesized in
fasciculate cells) levels are unaffected by the absence of NCδ
gene.
The increased plasma aldosterone level in the NCδ+/− mice
correlates with the increase in blood pressure. Systolic blood
pressure (measured by the non-invasive tail cuff method) was
determined to be 92 ± 6 mm Hg for the wild type mice and
127 ± 9 mm Hg for the NCδ+/− mice. Therefore, the conclusion
of these studies was that the ANF-RGC-Ca2+-NCδ transduc-
tion system is not only physically present but is of physiological
signiﬁcance at least in the adrenal gland.
In summary, this review has high-lighted studies which
deﬁne the molecular and physiological mechanisms of the hor-
monal signal transduction of ANF-RGC. In addition, a new
signal transduction mechanism and its present state of validation
has been narrated. In this model Ca2+ is the additional sig-
nal of ANF-RGC. By entirely different mechanism, it regu-
lates ANF-RGC catalytic activity and controls its physiological
functions.
FUTURE DIRECTIONS
There are three venues through which, in these authors’ under-
standing, the future research will progress. The ﬁrst venue
is centered on the basic research to decipher (1) how the
669WTAPELL675 motif “communicates”with the catalytic domain
of ANF-RGC and signals its activation and (2) the mechanism
of NCδ-Ca2+ signaling of ANF-RGC activity. The second venue
relates to the physiology of both ANF-RGC signaling pathways
(1) establishing whether the Ca2+ signaling mechanism is oper-
ative in other tissues in addition to the adrenal gland and (2)
to determine the interrelationship of the hormonal and Ca2+
pathways. Finally, after deciphering the molecular and physio-
logical details of the two signaling pathway the third venue will
be translational, to design a molecule that can target directly
the catalytic domain and bring ANF-RGC to its full activity
and prevent the pandemic of hypertension, myocardial hyper-
trophy and obesity. The last objective is the most far-reaching,
but hopefully can be achieved after the ﬁrst two goals are
accomplished.
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